IPO
-
-
-
-
-
-
-
Syros Pharmaceuticals (SYRS) Misses Q3 EPS by 11c
-
-
-
-
-
-
-
Syros Pharmaceuticals Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
-
-
-
-
99,556 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All